Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab.
| Image |  |
|---|---|
| Description | scientific article published on 15 March 2019 |
| Author/s |
author: Piotr Czapiewski |
| Publication date | March 15, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |